Updated May 29 at 11:25am
Health Services
684 results total, viewing 491 - 500
Rhode Island falls in the middle of the pack when it comes to the best states to have a baby, ranking 25th, according to WalletHub. more
Federal, state and a welter of community leaders recently participated in a kickoff event at Rhode Island College for Rhode Island’s own series of rallies marking National Recovery Month. more
Medical science in the Brown University Department of Health Services, Policy and Practice as well as research health scientist at the Providence Veterans Administration Medical Center discusses a study establishing the effectiveness of flu vaccines among the elderly. more
The Autism Project and Bristol Rotary Charities Foundation recently announced a new East Bay Support Center to serve individuals with autism spectrum disorder (ASD), as well as their families and the clinicians who support them. more
Citing research indicating a tamping down of smoking rates around the United States resulting from its decision to stop selling tobacco, CVS Health recently observed the one-year anniversary of its new way of doing business. more
The four members of Rhode Island’s congressional delegation all recently received petitions from individuals representing One Degree, a nationwide effort to increase medical research at the National Cancer Institute by $1 billion over two years. more
In 1990, the obesity rate in Rhode Island was about 10 percent. Today it's 27.4 percent and according to the Robert Wood Johnson Foundation, projected to be more than 50 percent by 2030. That means we are headed for having 500,000 obese … more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to monitor the heart and repair damaged valves. more
CVS Health Corp.’s move a year ago to give up tobacco seems to be helping some smokers stop or cut back as well. more
Novartis AG began selling the first copy of a biotechnology drug in the U.S., offering a 15 percent discount to the original after a U.S. appeals court rejected Amgen Inc.’s last-ditch effort to protect its blockbuster cancer drug Neupogen. more
« Prev | 1 47 | 48 | 49 | 50 | 51 | 52 | 53 69 | Next »